Simpson, Colin R. http://orcid.org/0000-0002-5194-8083
Kerr, Steven
Katikireddi, Srinivasa Vittal http://orcid.org/0000-0001-6593-9092
McCowan, Colin
Ritchie, Lewis D.
Pan, Jiafeng
Stock, Sarah J. http://orcid.org/0000-0003-4308-856X
Rudan, Igor
Tsang, Ruby S. M. http://orcid.org/0000-0002-2520-526X
de Lusignan, Simon http://orcid.org/0000-0002-8553-2641
Hobbs, F. D. Richard
Akbari, Ashley http://orcid.org/0000-0003-0814-0801
Lyons, Ronan A. http://orcid.org/0000-0001-5225-000X
Robertson, Chris
Sheikh, Aziz http://orcid.org/0000-0001-7022-3056
Funding for this research was provided by:
RCUK | Medical Research Council (MC_PC 19075)
Article History
Received: 27 January 2022
Accepted: 22 July 2022
First Online: 15 August 2022
Competing interests
: A.S. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group and its Standing Committee on Pandemics; the UK Government’s New and Emerging Respiratory Virus Threats (NERVTAG) Risk Stratification Subgroup; and was a member of AstraZeneca’s COVID-19 Thrombocytopenia Taskforce. All roles are remunerated to A.S. or his institution. C.R.S. declares funding from the MRC, NIHR, CSO, and New Zealand Ministry for Business, Innovation and Employment and Health Research Council during the conduct of this study. SVK is co-chair of the Scottish Government’s Expert Reference Group on COVID-19 and ethnicity, is a member of the Scientific Advisory Group on Emergencies (SAGE) subgroup on ethnicity and acknowledges funding from a NRS Senior Clinical Fellowship (SCAF/15/02), MRC (MC_UU_00022/2) and CSO (SPHSU17). C.R. is a member of the Scottish Government Chief Medical Officer’s COVID-19 Advisory Group, SPI-M, MHRA Vaccine Benefit and Risk Working Group. All other authors report no competing interests.